BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 11314029)

  • 21. Characterization of the inhibition of protein degradation by insulin in L6 cells.
    Fawcett J; Hamel FG; Duckworth WC
    Arch Biochem Biophys; 2001 Jan; 385(2):357-63. PubMed ID: 11368017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.
    Bossis G; Malnou CE; Farras R; Andermarcher E; Hipskind R; Rodriguez M; Schmidt D; Muller S; Jariel-Encontre I; Piechaczyk M
    Mol Cell Biol; 2005 Aug; 25(16):6964-79. PubMed ID: 16055710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myristylation of FBR v-fos dictates the differentiation pathways in malignant osteosarcoma.
    Jotte RM; Holt JT
    J Cell Biol; 1996 Oct; 135(2):457-67. PubMed ID: 8896601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential directing of c-Fos and c-Jun proteins to the proteasome in serum-stimulated mouse embryo fibroblasts.
    Salvat C; Jariel-Encontre I; Acquaviva C; Omura S; Piechaczyk M
    Oncogene; 1998 Jul; 17(3):327-37. PubMed ID: 9690514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deletion of the gag region from FBR murine osteosarcoma virus does not affect its enhanced transforming activity.
    Miller AD; Verma IM; Curran T
    J Virol; 1985 Sep; 55(3):521-6. PubMed ID: 2991577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. fau cDNA encodes a ubiquitin-like-S30 fusion protein and is expressed as an antisense sequence in the Finkel-Biskis-Reilly murine sarcoma virus.
    Michiels L; Van der Rauwelaert E; Van Hasselt F; Kas K; Merregaert J
    Oncogene; 1993 Sep; 8(9):2537-46. PubMed ID: 8395683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. c-Fos proto-oncoprotein is degraded by the proteasome independently of its own ubiquitinylation in vivo.
    Bossis G; Ferrara P; Acquaviva C; Jariel-Encontre I; Piechaczyk M
    Mol Cell Biol; 2003 Oct; 23(20):7425-36. PubMed ID: 14517309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A cryptic protease couples deubiquitination and degradation by the proteasome.
    Yao T; Cohen RE
    Nature; 2002 Sep; 419(6905):403-7. PubMed ID: 12353037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Degradation of c-Fos by the 26S proteasome is accelerated by c-Jun and multiple protein kinases.
    Tsurumi C; Ishida N; Tamura T; Kakizuka A; Nishida E; Okumura E; Kishimoto T; Inagaki M; Okazaki K; Sagata N
    Mol Cell Biol; 1995 Oct; 15(10):5682-7. PubMed ID: 7565719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proto-oncogene fos: an inducible gene.
    Verma IM; Mitchell RL; Sassone-Corsi P
    Princess Takamatsu Symp; 1986; 17():279-90. PubMed ID: 3332016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Facilitation of proteasomal degradation of p27Kip1 by N-terminal cleavage and their sequence requirements.
    Hirano K; Ihara E; Hirano M; Nishimura J; Nawata H; Kanaide H
    FEBS Lett; 2004 Sep; 574(1-3):111-5. PubMed ID: 15358549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A single amino acid substitution in a proteasome subunit triggers aggregation of ubiquitinated proteins in stressed neuronal cells.
    Li Z; Arnaud L; Rockwell P; Figueiredo-Pereira ME
    J Neurochem; 2004 Jul; 90(1):19-28. PubMed ID: 15198663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteasome-mediated degradation of the C-terminus of the Alzheimer's disease beta-amyloid protein precursor: effect of C-terminal truncation on production of beta-amyloid protein.
    Nunan J; Williamson NA; Hill AF; Sernee MF; Masters CL; Small DH
    J Neurosci Res; 2003 Nov; 74(3):378-85. PubMed ID: 14598314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determining protein half-lives.
    Zhou P
    Methods Mol Biol; 2004; 284():67-77. PubMed ID: 15173609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are there multiple proteolytic pathways contributing to c-Fos, c-Jun and p53 protein degradation in vivo?
    Salvat C; Aquaviva C; Jariel-Encontre I; Ferrara P; Pariat M; Steff AM; Carillo S; Piechaczyk M
    Mol Biol Rep; 1999 Apr; 26(1-2):45-51. PubMed ID: 10363646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FBR murine osteosarcoma virus. I. Molecular analysis and characterization of a 75,000-Da gag-fos fusion product.
    Curran T; Verma IM
    Virology; 1984 May; 135(1):218-28. PubMed ID: 6203214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. c-Fos degradation by the proteasome. An early, Bcl-2-regulated step in apoptosis.
    He H; Qi XM; Grossmann J; Distelhorst CW
    J Biol Chem; 1998 Sep; 273(39):25015-9. PubMed ID: 9737957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fos family protein degradation by the proteasome.
    Gomard T; Jariel-Encontre I; Basbous J; Bossis G; Moquet-Torcy G; Piechaczyk M
    Biochem Soc Trans; 2008 Oct; 36(Pt 5):858-63. PubMed ID: 18793151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myristylation-dependent transactivation by FBR v-fos is regulated by C/EBP.
    Jotte RM; Kamata N; Holt JT
    J Biol Chem; 1994 Jun; 269(23):16383-96. PubMed ID: 8206947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myristylation alters DNA-binding activity and transactivation of FBR (gag-fos) protein.
    Kamata N; Jotte RM; Holt JT
    Mol Cell Biol; 1991 Feb; 11(2):765-72. PubMed ID: 1846672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.